Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop
about
Bioinformatic analysis of HIV-1 entry and pathogenesis.Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interactionHuman monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1.A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.An evolutionary-network model reveals stratified interactions in the V3 loop of the HIV-1 envelope.Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and MacaquesA V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.Dissociation of the CD4 and CXCR4 binding properties of human immunodeficiency virus type 1 gp120 by deletion of the first putative alpha-helical conserved structure.Probing the Impact of Local Structural Dynamics of Conformational Epitopes on Antibody Recognition.Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.The role of the third beta strand in gp120 conformation and neutralization sensitivity of the HIV-1 primary isolate DH012Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles.A single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop.Isolate-specific differences in the conformational dynamics and antigenicity of HIV-1 gp120.Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms.The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cellsAdaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine seraRegions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virusMediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41.Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid)Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies.Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell lineSingle amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revertHumoral response to oligomeric human immunodeficiency virus type 1 envelope protein.Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cellsAntibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein.Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites.Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genesEnhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody.Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off.Structural analysis of a novel rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region critical for receptor and co-receptor binding.Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.Identification of the B cell superantigen-binding site of HIV-1 gp120.CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.
P2860
Q27693321-B41FA91C-8649-485B-A901-C131698285A2Q28369689-087FDE6B-2795-4EBD-83E4-A1C3264BFF3FQ29619512-AE1A4C36-72B9-41FA-A223-1C2F4F3D27A4Q30420728-3E27DE3E-FFE1-4278-B43D-4B1B6BEFD04CQ31143293-FC607B84-382B-44F2-99D5-6FB870D97404Q33307183-3011F716-BDA5-44E5-8CCE-68A49279BF22Q33683203-3F52B6A2-B563-48F8-814D-308179E5DC3DQ33725702-7250B36C-3E82-4D7E-8B4F-D3FA3D5AEFD1Q33783829-40AB0770-9162-41A4-8A9D-64D9C57C87EFQ33821896-6922D44B-2292-445A-9F7F-68EA791CF7F6Q33842152-925D6E75-E37A-4970-9542-64E827AA3D67Q33953062-19C47CCB-D75A-4FB8-B9B8-CC257818E196Q34292765-61318DF6-FAC3-4A34-B9DC-E6FDDE5A9F8DQ34406977-C8CEB521-D47F-4A00-89B1-1B0BA69C2F0CQ34463861-65DCC9DB-70D7-4D31-AB26-E0AB3E8CBAAFQ34885869-1264E788-1BA0-41D6-9B9C-26D1318F421AQ35330357-3F80EBAC-5890-4CE0-98A6-11F02390FDF3Q35737800-C9E24A8A-C733-47F0-B108-2007DF3622C8Q35828529-2B220E09-F31B-4B33-822B-89668E8CCE6DQ35833044-56B1AA04-A46E-456A-8EF8-ADCC87EDF9A2Q35837553-67F954E0-8C37-4DA6-9DE0-EB717ACB3D20Q35838613-F4A88954-2ABD-451D-A177-2E718FAA8EBBQ35839457-85558DB2-CA24-4B82-86E2-6378BF67D31FQ35845976-D814B579-5115-467D-BEC6-2843C2E7DF03Q35848446-CB6A4D1B-201F-4EA4-9F76-9A81868F6ACDQ35851603-F94408B6-31ED-4B46-BB04-568EEFE3A30BQ35853972-0209068C-5AB7-4561-90FD-5960A4ECF3A3Q35854300-0E6BB77D-3F7D-4A1F-8DF7-B2FDE2E96D5AQ35855710-A6598316-C287-4494-9928-3DCEDAEF1B9DQ35857331-B506DABB-8A12-4007-A653-A3B44039C867Q35873306-0CE9AF11-45D9-4DA6-B23C-B504E5731EA4Q35876927-851E25D9-420E-4BDC-8A03-A934F02140FBQ35890076-BB00971A-B635-4A92-9FA2-B22EE96F5AA4Q35892184-D11E8BE0-0771-4DD5-8D93-81A68655ED36Q35909563-B0D3BC7E-DE4A-4539-ACC0-ABC3C71EBDA7Q35973601-8C46C4C1-5D83-43E6-AC7C-A56B71C0659EQ35996612-697076A9-A599-49AD-BB77-6A5579A551E7Q36097829-5F68FB79-3FF9-4792-A1EF-2F240FF34C5AQ36365085-DAA1074A-043B-4614-88EB-2DBC12A109F6Q36366296-A2808810-B7C4-40D8-A5AE-EFA44B05669A
P2860
Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Immunochemical analysis of the ...... the C4 domain with the V3 loop
@ast
Immunochemical analysis of the ...... the C4 domain with the V3 loop
@en
type
label
Immunochemical analysis of the ...... the C4 domain with the V3 loop
@ast
Immunochemical analysis of the ...... the C4 domain with the V3 loop
@en
prefLabel
Immunochemical analysis of the ...... the C4 domain with the V3 loop
@ast
Immunochemical analysis of the ...... the C4 domain with the V3 loop
@en
P2093
P2860
P1433
P1476
Immunochemical analysis of the ...... the C4 domain with the V3 loop
@en
P2093
B A Jameson
P2860
P304
P407
P50
P577
1993-08-01T00:00:00Z